ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
Stock Snapshot
ACADIA Pharmaceuticals(ACAD) stock is priced at $21.74, giving the company a market capitalization of 3.71B. It carries a P/E multiple of 9.45.
As of 2026-04-12, ACADIA Pharmaceuticals(ACAD) stock has fluctuated between $21.42 and $22.60. The current price stands at $21.74, placing the stock +1.5% above today's low and -3.8% off the high.
The ACADIA Pharmaceuticals(ACAD)'s current trading volume is 841.56K, compared to an average daily volume of 1.49M.
In the last year, ACADIA Pharmaceuticals(ACAD) shares hit a 52-week high of $28.35 and a 52-week low of $13.73.
In the last year, ACADIA Pharmaceuticals(ACAD) shares hit a 52-week high of $28.35 and a 52-week low of $13.73.
ACAD News
Acadia Pharmaceuticals has recently confirmed that DAYBUE STIX, a dye- and preservative-free powder formulation of trofinetide for Rett syndrome in patients age...
RBC Capital lowered the firm’s price target on Acadia Pharmaceuticals (ACAD) to $29 from $30 and keeps an Outperform rating on the shares as part of the firm’s...
Analyst ratings
76%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.